News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
125,435 Results
Type
Article (3729)
Company Profile (13)
Press Release (121691)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (33249)
Career Advice (67)
Deals (6756)
Drug Delivery (11)
Drug Development (13520)
Employer Resources (6)
FDA (3427)
Job Trends (1960)
News (58782)
Policy (5795)
Tag
2027 Pharm Country Standard (1)
Academia (254)
Accelerated approval (7)
Allergies (32)
Alliances (11969)
ALS (21)
Alzheimer's disease (278)
Antibody-drug conjugate (ADC) (76)
Approvals (3582)
Artificial intelligence (71)
Autoimmune disease (18)
Automation (6)
Bankruptcy (14)
Best Places to Work (1678)
Biosimilars (82)
Biotechnology (14)
Bladder cancer (57)
Brain cancer (12)
Breast cancer (98)
Cancer (864)
Cardiovascular disease (47)
Career advice (62)
CAR-T (24)
CDC (1)
Cell therapy (89)
Cervical cancer (6)
Clinical research (12311)
Collaboration (369)
Compensation (27)
Complete response letters (5)
COVID-19 (337)
CRISPR (7)
C-suite (109)
Cystic fibrosis (13)
Data (1169)
Depression (13)
Diabetes (62)
Diagnostics (1226)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (48)
Drug pricing (13)
Drug shortages (1)
Duchenne muscular dystrophy (57)
Earnings (12427)
Editorial (3)
Employer resources (6)
Events (14199)
Executive appointments (105)
FDA (4118)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (196)
Gene editing (12)
Generative AI (7)
Gene therapy (60)
GLP-1 (125)
Government (519)
Grass and pollen (2)
Guidances (80)
Healthcare (2423)
HIV (10)
Huntington's disease (3)
IgA nephropathy (21)
Immunology and inflammation (16)
Immuno-oncology (10)
Indications (31)
Infectious disease (393)
Inflammatory bowel disease (36)
Inflation Reduction Act (2)
Influenza (31)
Intellectual property (47)
Interviews (4)
IPO (2712)
Job creations (371)
Job search strategy (57)
JPM (5)
Layoffs (13)
Legal (1339)
Liver cancer (18)
Longevity (1)
Lung cancer (135)
Lymphoma (77)
Machine learning (4)
Manufacturing (141)
MASH (21)
Medical device (2572)
Medtech (2581)
Mergers & acquisitions (4289)
Metabolic disorders (144)
Multiple sclerosis (28)
NASH (1)
Neurodegenerative disease (54)
Neuropsychiatric disorders (9)
Neuroscience (479)
NextGen: Class of 2026 (629)
Non-profit (292)
Obesity (59)
Opinion (12)
Ovarian cancer (26)
Pain (28)
Pancreatic cancer (23)
Parkinson's disease (56)
Partnered (6)
Patents (79)
Patient recruitment (84)
Peanut (8)
People (8286)
Pharmaceutical (4)
Pharmacy benefit managers (4)
Phase 1 (3223)
Phase 2 (5170)
Phase 3 (4742)
Pipeline (1099)
Policy (10)
Postmarket research (460)
Preclinical (1167)
Press Release (47)
Prostate cancer (47)
Psychedelics (1)
Radiopharmaceuticals (43)
Rare diseases (97)
Real estate (1027)
Recruiting (1)
Regulatory (4788)
Reports (16)
Research institute (228)
Resumes & cover letters (9)
RNA editing (2)
RSV (15)
Schizophrenia (35)
Series A (37)
Series B (38)
Service/supplier (1)
Sickle cell disease (11)
Spinal muscular atrophy (9)
Sponsored (4)
Startups (572)
Stomach cancer (2)
Supply chain (17)
Tariffs (1)
The Weekly (2)
Vaccines (121)
Venture capital (7)
Weight loss (27)
Women's health (6)
Date
Today (21)
Last 7 days (84)
Last 30 days (353)
Last 365 days (4985)
2026 (545)
2025 (5078)
2024 (5989)
2023 (6679)
2022 (11917)
2021 (12025)
2020 (10978)
2019 (7875)
2018 (5962)
2017 (6213)
2016 (5740)
2015 (6877)
2014 (5100)
2013 (4413)
2012 (4601)
2011 (4655)
2010 (4150)
Location
Africa (153)
Alabama (4)
Alaska (2)
Arizona (20)
Arkansas (2)
Asia (24209)
Australia (3496)
California (1284)
Canada (605)
China (429)
Colorado (26)
Connecticut (99)
Delaware (42)
Europe (24864)
Florida (136)
Georgia (82)
Idaho (5)
Illinois (92)
India (42)
Indiana (97)
Iowa (6)
Japan (271)
Kansas (12)
Louisiana (1)
Maine (9)
Maryland (160)
Massachusetts (979)
Michigan (20)
Minnesota (85)
Missouri (20)
Montana (6)
Nebraska (2)
Nevada (17)
New Hampshire (15)
New Jersey (835)
New Mexico (9)
New York (407)
North Carolina (208)
North Dakota (2)
Northern California (645)
Ohio (13)
Oklahoma (1)
Oregon (2)
Pennsylvania (228)
Puerto Rico (1)
Rhode Island (2)
South America (173)
South Carolina (3)
Southern California (490)
Tennessee (17)
Texas (131)
United States (5162)
Utah (34)
Virginia (54)
Washington D.C. (8)
Washington State (88)
Wisconsin (18)
Wyoming (1)
125,435 Results for "snbl usa ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Satsuma Pharmaceuticals and SNBL Announce Publication of Impression of Use and Satisfaction with STS101 (Dihydroergotamine Nasal Powder (Atzumi™)) in Headache
November 6, 2025
·
7 min read
Press Releases
SNBL and Tasso, Inc. to Establish Joint Venture in Japan
March 28, 2025
·
2 min read
Press Releases
Dexcel Pharma USA Acquires US Rights to Zubsolv®
January 8, 2026
·
1 min read
Press Releases
Satsuma Pharmaceuticals and SNBL Announce Four Abstracts to be Presented at the American Headache Society’s 67th Annual Scientific Meeting
June 19, 2025
·
5 min read
Press Releases
PharmaEssentia USA Announces Appointment of Jeffrey Williams as Independent Director
December 25, 2025
·
2 min read
Press Releases
IBSA USA Announces FDA Approval of VYBRIQUE™, the First and Only Oral Film to Treat Men with Erectile Dysfunction
February 5, 2026
·
7 min read
Press Releases
Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline
February 4, 2026
·
19 min read
Press Releases
Shimadzu Medical Systems USA announces the release of the SC15
November 24, 2025
·
2 min read
Press Releases
Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market
November 27, 2025
·
3 min read
Press Releases
PharmaEssentia USA Announces Appointment of Dr. Barry Flannelly as Independent Director
November 10, 2025
·
2 min read
1 of 12,544
Next
